Broker Research
March 04, 2025 / 12:11 IST
Reported Consolidated quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 24.73 crore in December 2024 up 33.34% from Rs. 18.55 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.19 crore in December 2024 up 12.48% from Rs. 5.93 crore in December 2023.
EBITDA stands negative at Rs. 2.42 crore in December 2024 down 24.74% from Rs. 1.94 crore in December 2023.
ANG Lifescience shares closed at 33.21 on March 03, 2025 (BSE) and has given -31.48% returns over the last 6 months and -46.44% over the last 12 months.
ANG Lifesciences India | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | Net Sales/Income from operations | 24.73 | 32.88 | 18.55 | Other Operating Income | -- | -- | -- | Total Income From Operations | 24.73 | 32.88 | 18.55 | EXPENDITURE | Consumption of Raw Materials | 16.90 | 24.13 | 13.58 | Purchase of Traded Goods | -- | -- | -- | Increase/Decrease in Stocks | -0.85 | -2.68 | -2.00 | Power & Fuel | -- | -- | -- | Employees Cost | 4.44 | 4.58 | 4.49 | Depreciation | 1.96 | 1.74 | 1.91 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 6.38 | 4.57 | 4.39 | P/L Before Other Inc., Int., Excpt. Items & Tax | -4.11 | 0.55 | -3.82 | Other Income | -0.27 | 0.35 | -0.03 | P/L Before Int., Excpt. Items & Tax | -4.38 | 0.89 | -3.85 | Interest | 2.00 | 2.18 | 2.51 | P/L Before Exceptional Items & Tax | -6.38 | -1.29 | -6.37 | Exceptional Items | -- | -- | -- | P/L Before Tax | -6.38 | -1.29 | -6.37 | Tax | -1.19 | 0.80 | -0.44 | P/L After Tax from Ordinary Activities | -5.19 | -2.09 | -5.93 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -5.19 | -2.09 | -5.93 | Minority Interest | -- | -- | -- | Share Of P/L Of Associates | -- | -- | -- | Net P/L After M.I & Associates | -5.19 | -2.09 | -5.93 | Equity Share Capital | 13.06 | 13.06 | 13.06 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -3.98 | -1.53 | -4.53 | Diluted EPS | -3.98 | -1.53 | -4.53 | EPS After Extra Ordinary | Basic EPS | -3.98 | -1.53 | -4.53 | Diluted EPS | -3.98 | -1.53 | -4.53 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!